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Abstract 
Periodontitis is a chronic inflammatory disease caused by bacterial invasion of the 
gingival epithelial cells within the oral cavity (Bostanci and Belibasakis, 2012). A key 
bacterium responsible for this is Porphyromonas gingivalis (P. gingivalis), a gram 
negative bacterium that evades the host immune system by cell infection. The 
chronic inflammation shown in periodontitis can cause tissue damage and bone 
degradation; this can lead to tooth loss (Hajishengallis et al 2011). Within this review 
P.gingivalis mechanisms of infection are outlined, along with its mediation of the 
immune system. Recognition by Toll like receptors is also investigated, and the 
literature on the manipulation of toll like receptors (TLRs) as mediators of 
inflammation is reviewed. The discovery of macrophage phenotypes and their 
expression of pro and anti-inflammatory cytokines are outlined, with reference to the 
potential use of human TLR7 inhibitor imiquimod, as a potential way of reducing 
inflammation within periodontitis. 
 
 
 
 
 
 
 
The Plymouth Student Scientist, 2013, 6, (2), 355-367  
 
 
[356] 
 
Porphyromonas gingivalis 
Porphyromonas gingivalis is a gram negative, biofilm forming, anaerobic bacterium, 
found within the oral cavity (Bostanci and Belibasakis, 2012). It is an opportunistic 
pathogen, and once it has infiltrated the cells it can cause acute inflammation of the 
gingival epithelial cells (Gingivitis). Chronic inflammation can lead to disease 
progression to periodontitis causing tissue necrosis and bone degradation 
(Hajishengallis et al 2011). 
Attachment 
Invasion of the gingival epithelial cells by P.gingivalis starts with the formation of a 
subgingival biofilm within the periodontal pocket (Kuboniwa and Lamont, 2010). This 
biofilm consists of multiple oral pathogens including: Aggregatibacter 
actinomycetemcomitans, porphyromonas gingivalis,Tannerella forsythia, Prevotella 
intermedia, Prevotella nigrescens, Fusobacterium nucleatum and Parvimonasmicra 
(Veloo et al 2012). The anaerobic conditions within the periodontal pocket, along 
with a close proximity to blood flow to provide heme, provides an optimal area for 
P.gingivalis colonisation, due to its need for heme and vitamin K for survival. This 
has been shown by a study into P.gingivalis concentrations in relation to periodontal 
pocket depth, measured via PCR. Results have shown that for every mm in depth 
the number of P.gingivalis cells increased 10-fold (Kawada et al 2004). P.gingivalis is 
found in 85% of chronic forms of periodontitis and thus is most associated with the 
disease (Yang et al 2004). It is considered to be a late coloniser and thus is closer to 
the gingival epithelium. The contact with the epithelium allows for Type 1 major 
fimbriae to bind to β integrin on host cell surfaces via focal adhesion kinase. 
Infection of the gingival epithelial cell 
 After attachment, phosphorylation of c-jun N terminal Kinase (JNK) and down 
regulation of extracellular signal related kinase ERK1/2 allows for the bacterium to 
enter the gingival epithelial cell without detection. This is due to the down regulation 
of nuclear factor kappa B (NF-kB) inhibiting IL-8 secretion and apoptosis (Yilmaz et 
al 2003). The inhibition of IL-8 means that P.gingivalis can avoid neutrophil 
chemotaxis due to IL-8 being necessary for both neutrophil migration to the infected 
cell and adhesion (Hammond et al 1995). Degradation of IL-1β, IL-6 and sICAM has 
also been found within the infected gingival epithelial cell (Neil et al 2009). After 
internalisation the bacterium induces nucleation of the actin filaments on the host cell; 
this creates microspike-like protrusions and long stable microfilaments distributed 
throughout the cell, within 24 hours the actin and tubulin cytoskeleton is remodelled 
shown by fluorescence microscopy (Yilmaz et al 2003). Within the cell P.gingivalis 
can maintain viability and replicate (Belton et al 1999). 
Survival in the host cell  
Survival in host cells is maintained through the release of ATP-hydrolysing enzyme 
to suppress ATP-dependant apoptosis as well as activation of PI3K/Akt pathways, 
JAK/Stat pathways, down regulation of caspase 3 activity and an up regulation in 
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Bcl-2 levels (Nakhjiri et al 2001). Dissemination to neighbour cells via actin bridges 
allows for the infection to spread without activating the immune response (Yilmaz et 
al 2006). P.gingivalis can also manipulate proliferation of the gingival epithelial cell, 
up regulating proliferation and thus increasing the depth of the periodontal cavity. 
This was confirmed via cytofluorimetry that showed proliferation was increased due 
to accelerated progression through S phase (Kuboniwa et al 2008). 
Interaction with the immune system 
Once the number of P.gingivalis bacterium has grown substantially, production of 
pro-inflammatory cytokines IL-8, IL-6, IL-1β and sICAM-1in the gingival epithelial 
cells occur. A reason for this may be that recruitment of the immune system to the 
area of infection increases angiogenesis, this in turn would bring the heme needed to 
sustain the larger amount of P.gingivalis bacterium (Bostanci and Belibasakis  2012, 
O’Brien-Simpson et al 2009).  
P.gingivalis can also enter macrophages by the use of Complement receptor 3 
(CR3)(CD11b/CD18). This is done through the use of inside out signalling to activate 
the ligand binding capacity of CR3, via interactions between fimbrial accessory 
Proteins and TLR2 (Figure 1). Once inside the cell P.gingivalis can inhibit IL-12p70 
production consequently reducing T-cell activation (Wang et al 2007). Persistence of 
P.gingivalis within the macrophage may also be related to CR3, with wild type 
P.gingivalis showing a higher intracellular persistence compared to DAP type 
fimbriae containing P.gingivalis. A CR3 deficiency within macrophages causes an 
increase in intracellular killing of wild type P.gingivalis, consistent with the hypothesis 
that CR3-mediated internalisation increases intracellular persistence of P.gingivalis. 
 
Figure 1: Modified from Wang et al 2007 
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Lipopolysaccharides (LPS) enable discrimination between commensal and 
pathogenic species through TLRs and CD14. P.gingivalis LPS is a pro-inflammatory 
cytokine stimulator, as well as a stimulator of bone resorption (Nishida et al 2001). 
However P.gingivalis is a slightly weaker cytokine stimulator than other LPS models. 
This may be due to differences in the O-antigen between P.gingivalis strains. These 
differences have a role in the acylation patterns and the receptor activating capacity 
of lipid A component.  P.gingivalis’ s lipid A, unlike most gram-negative bacterium, 
activates TLR2 instead of TLR4. In fact Darveau et al (2004) stated that the LPS 
may be an antagonist of TLR4. This is due to there being two different types of lipid 
A, tetra-acylated (TLR4 antagonist) and penta-acylated (TLR4 agonist). Dependant 
on heme concentrations, P.gingivalis can switch between the two types of lipid A, 
mediating the effect of host immune signalling (Al-Qutub et al 2006). 
 Investigation in to P.gingivalis LPS by Pulendran et al (2001) shows that P.gingivalis 
LPS activates CD8α+ and CD8α- dendritic cells as well as murine peritoneal 
macrophages (Pulendran et al 2001). This results in the production of IL-6, and 
TNFα. However unlike E.coli LPS it does not induce IL-12 production. P.gingivalis 
LPS also stimulates metalloprpteinase-9 (MMP-9) expression in dendritic cells. 
MMP-9 is responsible for collagen cleavage for leukocyte migration towards the 
vasculature and lymphatic system. In a study with human monocyte derived dendritic 
cells it was shown that P.gingivalis increased expression of MMP-9, more than the 
tissue inhibitor of metalloproteinase-1 (TIMP-1) a regulator of MMP-9. Without 
regulation, excess amounts of MMP-9 cause large amounts of tissue destruction 
(Jotwani et al 2010). 
The capsular polysaccharide (CPS) on P.gingivalis has the ability to generate 
systemic IgG antibody responses (Sims et al 2001), as well as resisting 
phagocytosis. Whereas cell surface cysteine proteinases called gingipains allow 
cleavage of CD2, CD4 and CD8 down regulating the immune response (Kitamura et 
al 2002). Gingipains also up regulate neutrophil protease activated receptor 
expression in neutrophils, Gingival epithelial cells, fibroblast and T-cells, crucial for 
chronic inflammation in periodontitis (Holzhausen et al 2010). 
The combination of these virulence factors provides P.gingivalis with the tools to 
interact with the immune response, depending on extracellular factors. This along 
with our lack of understanding behind the molecular biology of many processes 
means that finding ways to effectively combat periodontitis are difficult. A way of 
combating periodontitis may be by reducing inflammation; this would decrease the 
amount of heme to the area as well as reduce tissue damage. This has been 
investigated with Rheumatoid arthritis, a chronic inflammatory disease of synovial 
joints (Sacre et al 2010). 
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Rheumatoid Arthritis  
Rheumatoid arthritis (RA) is similar to periodontitis, as both are chronic inflammatory 
diseases. Also both result in the destruction of tissue and bone degradation due to 
persistent synthesis of pro-inflammatory cytokines, including TNFα and IL-6 as well 
as MMP (Midwood et al 2009). Both Periodontitis and RA share HLA-DRB1 alleles 
as well as sharing the same inflammatory pathways (Mikuls et al 2012). 
Within RA TNFα has been highlighted as having a key role in inflammation 
(Davignon et al 2012). This is due to the blocking of TNFα causing a down regulation 
in other pro-inflammatory cytokines: IL-1β, IL-6 and IL-8, expressed by macrophages. 
It has also been suggested that P.gingivalis may play a role in early loss of tolerance 
to RA self-antigens (Mikuls et al 2012).  
Anti-TNF reagents have been shown to reduce inflammation and bone erosion in 
some models; it works by reducing pro-inflammatory cytokines within the area and 
thus reducing inflammation. However anti-TNF treatments do not work for everyone 
(Fieldman et al 2010). 
Toll like receptors 
Toll like receptors (TLRs) are pattern recognition receptors (PRRs) that recognise 
molecular patterns on pathogens, known as pathogen-associated molecular patterns 
(PAMPs). Activation of periodontium cell TLRs by bacterial PAMPs lead to a release 
of pro-inflammatory cytokines, which elicit an inflammatory immune response that 
causes the damage to the surrounding tissue; as seen in periodontitis (Hans and 
Hans, 2011).  
TLRs are part of a superfamily called the interleukin 1 Receptor/Toll-like receptor 
super-family. All members of the super family express Toll-IL-1 TIR domains which  
 
 
Figure 2: modified from Pennini et al 2012, showing the TLR 2 and 4 
signalling pathways 
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are receptors for macrophage secreted interleukins (Hans and Hans 2011).  
TLRs consist of a C-terminal cytoplasmic TIR domain, responsible for protein to 
protein interaction within innate immunity. This is connected to an N-terminal 
Leucine-rich repeat on the extracellular surface (LRR) that is responsible for Ligand 
binding and signalling. Within human cells TLRs 1, 2, 4, 5 and 6 are expressed on 
the cell surface membrane, whereas TLRs 3, 7, 8 and 9 are expressed intracellularly 
and specifically detect viral or bacterial nucleic acids.  There are 10 TLRs that have 
been found to be expressed within human cells, however macrophages express 
TLRs 1, 2, 4, 5, 6, 7 and 8. P.gingivalis is known to stimulate TLRs 2 and 4, both 
receptors of LPS (Hans and Hans, 2011), yet other TLRs may also be activated. 
Research in to TLR activation of periodontal ligament and gingival fibroblast, after 
stimulation with P.gingivalis, showed a stronger induction of TLR1 and TLR7 
(Scheres et al 2011). TLR1 induction may be due to TLR2 forming a heterodimer 
with the TLR1, and a reason for TLR7 induction may be that TLR7 plays a role in 
autophagy stimulation, in order to combat intracellular pathogens (Delgado et al 
2008). These results however, may be different within a macrophage model. 
Activation of TLR2 is unusual, as it is normally associated with the recognition of 
gram-positive bacterial components through heterodimerizing with TLR1 or TLR6 
(Pennini et al 2012). 
All TLRs activate NF-kB and MAP Kinase pathways (Figure 2). MyD88 is recruited in 
all but TLR4 and TLR3 signalling pathways, with TLR4 using both MyD88 dependant 
and independent signalling. (Pennini et al 2012) MyD88 dependant signalling recruits 
IL-1-receptor-associated kinases IRAK kinases: IRAK 1, 2 and 4 via death domains. 
IRAK kinases contribute to the myddosome, a critical multiprotein structure for TLR 
mediated signal transduction. Autophosphorylation of IRAK1 due to MyD88 
phosphorylation of TRAK4 allows recruitment of ubiquitin ligase TRAF6 (Suzuki et al 
2002). Ubiquitination of TRAF6 and TRAK1 enables interaction with IkB Kinase (IKK) 
complex. The IKK complex activates NF-kB transcription factor and MAP kinases 
ERK, p38 and JNK.(Brentano et al 2005) MyD88 independent signalling is via TRAM 
for TLR4 and TRIF dependant signalling for TLR3, resulting in pro-inflammatory 
cytokine production. (Pennini et al 2012, Brentano et al 2005). 
TLR7 activation 
TLR7 has been targeted for the regulation of inflammatory response within 
Rheumatoid arthritis (Alzabin et al 2012., Clanchy and Sacre, 2010). Mianserin was 
administered to arthritic mice daily after onset of disease. Results showed that 
inhibition of TLR7 decreased disease progression within mice models; However Mice 
model TLR7 is more like TLR8 within human models, and so may show differences 
when used in a human cell model. For example, Sacre et al (2008) investigates the 
inhibition of TLR8 to reduce TNF production in rheumatoid synovial membrane 
cultures. The use of Mianserin on human M-CSF macrophages showed a decrease 
in TNF production, inhibition via TLR8 was re-affirmed by the use of remiquimod (R-
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848) a TLR7/8 agonist.  The use of a TLR agonist as well as a TLR4 antagonist LPS, 
is a good way of ensuring activation through the desired TLR however finding an 
agonist specifically for TLR8 would help to enhance the results. Sacre et al (2008), 
found that inhibition of TLR8 could be achieved through the use of Imiquimod, a 
TLR7 agonist structurally similar to R-848. Also there was no effect with activation 
through LPS, showing that it did not act through inhibition of the high TNF producer 
TLR4. Further investigation could be in to whether or not production of TNF, after 
inhibition of TLR8 is effected by the macrophage phenotype. 
Imiquimod has also been used in relation to IFN-β production (O’Brien et al 2009). 
The study showed an increase in IFN-β expression; this induces IL-10 anti-
inflammatory cytokines thus working towards down regulating inflammation. The 
experiment was performed with 8 10-week old female mice. Imiquimod being a 
human and mouse TLR7 agonist may react differently in the human model. This is 
because the murine TLR7 behaves more like Human TLR8, which imiquimod has 
been suggested to inhibit in human macrophages (Sandre et al 2008).  
Research in to TLR7 activation on the skin has shown to promote respiratory 
dendritic and natural killer cell accumulation (Hackstein et al 2012). An increase in 
anti-inflammatory cytokines was also observed, implying a reduction in inflammation 
and suppression of cytotoxic CD8+T cells. This provides bases for further research in 
to murine TLR7, however as previously stated with other murine models there is still 
a need for investigation in to human TLR7/8 to provide any definitive results. 
Macrophage autophagy 
Macrophage autophagy and inflammation in atherosclerotic plaques, is shown to be 
induced by imiquimod (DeMeyer et al 2012). Imiquimod was chosen due to it being a 
TLR7 agonist; this allows specificity for targeting of the macrophage. Specificity is 
due to the smooth muscle cells (SMCs) not expressing TLR7 unlike the macrophage. 
A murine macrophage cell line was used as well as a human U937 cell line; this 
allows comparison between human and mouse cell lines. Also within the study TLR7 
knock out mouse, bone marrow derived macrophages were used; this is good as it 
provides the information to determine if it is in fact TLR7 dependant. Before 
introduction to imiquimod, human atherosclerotic plaques were stained using 
immunohistochemical staining; the reaffirmation that the plaques still expressed 
TLR7 justifies the research. It was found that imiquimod caused cell death within 24 
hours in macrophages and did not affect SMCs. Hyper phosphorylation of NF-kB in 
bone marrow derived macrophages, after introduction of imiquimod, induces 
inflammation via TLR7 expression, contradictory to previous studies where 
imiquimod is shown to down regulate inflammation in human models (Sandre et al 
2008). 
Autophagy allows for elimination of intracellular pathogens controlled by the 
recognition of PAMPs (Delgado et al 2008). Delgado et al, states that within 
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macrophages TLR7 was the most potent inducer of macrophage autophagy 
dependant on MyD88 expression. Autophagy induction is monitored by translocation 
of protein LC3 (ATg8) from the cytosol to newly formed autophagosomes. Within this 
study macrophages were transduced with fluorescent protein-LC3, 24 hours later 
Standard concentrations of PAMP were introduced as well as the inclusion of an 
autophagic control and a non-stimulus control. Results showed that TLR7 ligand 
produced the largest increase in LC3 puncta formation; this was then confirmed by 
the use of imiquimod as a TLR7 agonist at a concentration of 10µg/ml. MyD88 
knockdown within cells demonstrated that TLR7 stimulated autophagy is MyD88 
dependant. 
The macrophage and its phenotypes 
Macrophages play a major role in the innate immune response. Their ability to 
secrete a range of both pro-inflammatory and anti-inflammatory cytokines provides 
them with the ability to be key mediators in inflammation. Recent studies have shown 
there to be two phenotypes of macrophage; Classical activated (M1) and 
alternatively activated (M2), derived from monocytes after they are recruited in to the 
tissue via Chemokine signalling (Merry et al 2012). M1 macrophages are activated 
through LPS or IFN treatment; they’re known for an increased release of pro-
inflammatory cytokines such as IL-6 and TNFα, and are promoters of inflammation. 
Inducible nitric oxide synthase (iNOS) is also expressed within M1 macrophages; 
this enables the production of nitric oxide (NO) for microbicidal activity, which is not 
expressed in the M2 phenotype (Mege et al 2011). M2 macrophages are typically 
activated through the use of Th2 cytokines IL-4 and IL-13. The M2 macrophage 
expresses a higher concentration of anti-inflammatory cytokines like IL-10 and 
transforming growth factor- β (TGF-β), down-regulating pro-inflammatory cytokines in 
order to reduce inflammation (Merry et al 2012). These anti-inflammatory 
characteristics, along with their ability to help tissue regeneration via MMPs and 
growth factors, explain why M2 macrophages are more abundant within the resolving 
stages of inflammation (Weisser et al 2012., Merry et al 2012).  
Skewing of macrophage phenotype has been suggested to be plastic, with cases of 
both M1 and M2 macrophages in the same area implying that the phenotypes may 
not be definite.  Instead there may be a scale in which macrophages can move along 
dependant on the extracellular environment (Sica and Mantovani, 2012). Gemperle 
et al (2012) state that M2 macrophages have reduced amounts of formyl peptide 
receptor 1 (FPR1), stopping chemotaxis towards FPR1 ligand fMLF. This is however 
not true for M1 macrophages where chemotaxis was present. Further investigation 
into stimulation with a pro-inflammatory TLR4 agonist elevated chemotaxis, as well 
as FPR1 mRNA levels in M1 macrophages. This suggests that FPR1 expression 
promotes M1 activation and polarisation. The study could be taken further by 
investigating whether or not M2 macrophages can be stimulated into chemotaxis 
towards fMLF as they still express FPR1, even if it is in low amounts. This may be a 
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way of investigating the plasticity of macrophage phenotypes; if this is the case then 
it provides the possibility of using Macrophage phenotypes for the manipulation of 
inflammatory disease.   
Proposal for future research 
Activation of TLRs through P.gingivalis is not yet fully understood, with suggestions 
that it is not only recognised through TLRs 2 and 4 but TLR1 and 7 as well. Its 
avoidance of the innate and adaptive immunity through living within the host cells, as 
well as being able to mediate cytokine production, and in turn activation of immunity 
depending on what is most beneficial for the bacteria at the time, means that finding 
ways to fight periodontitis is a challenge. An area of exploitation may be with 
P.gingivalis’ s need for heme in order to survive. Down regulation of inflammation in 
the gingiva, as well as an up regulation of M2 macrophages may lead to a reduction 
in the concentration of P.gingivalis cells due to a lack of heme for them all to survive. 
This reduction in cell count, combined with the reduction of tissue destruction from 
pro-inflammatory leukocytes, my provide relief from periodontitis. 
So far imiquimod has been investigated for its TLR7 agonistic and TLR8 antagonistic 
properties within Human and murine cell bodies, yet there is no research on the 
effects of imiquimod on M1 and M2 human macrophages in relation to inflammatory 
cytokine production. If imiquimod induces a reduction in pro-inflammatory cytokines 
within M1 macrophages, like it has in RA models, then it may suggest a possibility in 
manipulating macrophage phenotypes for the control of chronic inflammation. 
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